However, in the subgroup of ESCC patients with lymph node metastasis, the OS of patients with low expression of UBQLN2 was significantly better than that of patients with high expression of UBQLN2 (P < 0.01) (Figure 1(d)). The gene discussed is UBQLN2; the disease is metastatic malignant neoplasm in the lymph nodes.